Privia Health Group Inc

Privia Health Group Inc(PRVA)股票分析

$20.640

+0.151 (+0.73%)收盘时

Loading chart…
High
21.030
Open
20.330
VWAP
20.67
Vol
1.07M
Mkt Cap
2.04B
Low
20.330
Amount
22.09M
EV/EBITDA, TTM
-59.89

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

AI analysis of Privia Health Group Inc (PRVA)

hold

Privia Health Group Inc is currently priced at $20.79, which is significantly below analyst price targets of $32 and $35, indicating potential upside. However, the RSI is at a low 20.94, suggesting the stock is oversold and may not be a good buy at this moment. The recent 12.4% year-over-year increase in practice collections and a 29% rise in adjusted EBITDA show strong operational performance, but the stock has seen a 12.17% decline over the past 20 days, indicating ongoing weakness. The main risk is the recent earnings miss, with reported EPS of 0.07 against an estimate of 0.08, which could dampen investor sentiment.

估值指标

The current forward P/E ratio for Privia Health Group Inc (PRVA) is 22.94, compared to its 5-year average forward P/E of 55.29.

Forward P/E

Fair
5Y Average P/E
55.29
Current P/E
22.94
高估
341.60
低估
-231.01

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-86.17
Current EV/EBITDA
-59.89
高估
956.39
低估
-1128.73

Forward P/S

Undervalued
5Y Average P/S
1.66
Current P/S
0.98
高估
2.19
低估
1.12

Alphio AI Price Scenarios for PRVA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PRVA

$29.18

情景价格

B

Base

Base · 50%PRVA

$27.83

情景价格

B

Bear

Bear · 25%PRVA

$24.83

情景价格

Whales holding PRVA

D

Durable Capital Partners, LP

+ HoldingPRVA

-0.46%

3M Return

事件时间线

2026-08-06 (ET)

06:30:00

FY26 Consensus at $2.42, Adjusted EBITDA Expected in $145M-$155M Range

06:30:00

Company Reports Q2 Revenue of $632.6M

2026-05-27 (ET)

09:10:00

Privia Health Signs Agreement with NGBC to Enter New Jersey

2026-05-07 (ET)

06:20:00

Company Reports Q1 Revenue of $603.8M, Exceeds Consensus

2026-02-26 (ET)

06:30:00

Expects Approximately $600M in Cash by Year-End 2026

资讯

PRVA FAQ — answered by Alphio AI

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

Privia Health Group Inc is currently priced at $20.79, which is significantly below analyst price targets of $32 and $35, indicating potential upside. However, the RSI is at a low 20.94, suggesting the stock is oversold and may not be a good buy at this moment. The recent 12.4% year-over-year increase in practice collections and a 29% rise in adjusted EBITDA show strong operational performance, but the stock has seen a 12.17% decline over the past 20 days, indicating ongoing weakness. The main risk is the recent earnings miss, with reported EPS of 0.07 against an estimate of 0.08, which could dampen investor sentiment.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始